Health-related Quality of Life (hrqol), Functioning, and Symptoms with Odronextamab Monotherapy in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (R/R FL) by POD24 Status in the ELM-2 Study.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined